ZBIO

ProShares UltraPro Short NASDAQ Biotechnology

Delisted

ZBIO was delisted on the 27th of March, 2020.

6 hedge funds and large institutions have $4.36M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
2
Closed
4
Calls
$857K
Puts
$2.35M
Net Calls
-$1.49M
Net Calls Change
-$3.03M
Name Holding Trade Value Shares
Change
Shares
Change %
EDRH
1
Edmond de Rothschild Holding
Switzerland
$1.79M +$1.79M +42,233 New
EDRS
2
Edmond de Rothschild (Suisse)
Switzerland
$1.79M +$1.79M +42,233 New
VF
3
Virtu Financial
New York
$496K -$358K -8,465 -42%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$259K +$27.9K +660 +12%
IA
5
IFP Advisors
Florida
$21K +$21K +500 New
CG
6
Cutler Group
California
$16K -$2K -50 -11%
Morgan Stanley
7
Morgan Stanley
New York
-$181K -2,795 Closed
Simplex Trading
8
Simplex Trading
Illinois
-$175K -2,720 Closed
UBS Group
9
UBS Group
Switzerland
-$33K -505 Closed
TRCT
10
Tower Research Capital (TRC)
New York
-$1K -22 Closed